SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-006402
Filing Date
2019-03-06
Accepted
2019-03-06 08:35:20
Documents
3
Period of Report
2019-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evok-8k_20190306.htm 8-K 31625
2 EX-99.1 evok-ex991_6.htm EX-99.1 199952
3 GRAPHIC goir1b4e0yly000001.jpg GRAPHIC 4748
  Complete submission text file 0001564590-19-006402.txt   239406
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 19661330
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences